Results 161 to 170 of about 30,070 (260)

Significance of Myelodysplasia‐Related Mutations and the Genetic Landscape of Acute Leukemias of Ambiguous Lineage

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 3, Page 512-520, June 2026.
ABSTRACT The recent fifth edition WHO classification and ICC classification systems have moved further toward genetically defined classifications of acute leukemias. Both now recognize myelodysplasia‐related (MR) mutations as defining of MDS‐related AML (AML‐MR).
Timothy J. Kirtek, Olga K. Weinberg
wiley   +1 more source

Targeted Therapy for a Rare PDGFRB-Rearranged Myeloproliferative Neoplasm: A Case Report. [PDF]

open access: yesInt J Mol Sci
Barbato C   +19 more
europepmc   +1 more source

Is Myeloproliferative Neoplasm with Splanchnic Vein Thrombosis a Distinct Clinical Entity?

open access: yes, 2015
Clinical History: A 29 year-old previously healthy female presented with sub-acute symptoms of weight loss, right upper quadrant pain and nausea. CBC results: WBC-11.7, Hb- 12.5, Platelet- 286, MCV- 90, MCV- 26.8, RDW- 18%.
Gong, MD, Jerald Z.   +2 more
core  

Digital Pathology in Hematopathology: From Vision to Deployment

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 3, Page 531-540, June 2026.
ABSTRACT Digital pathology (DP) has evolved alongside other technical advances, transforming our daily lives and diagnostic medicine. It is likely that, as in other areas of life, science, and medicine, the overall level of digitization will continue to rise, along with an increasing number of groups implementing DP.
Ryan C. Shean, Anton V. Rets
wiley   +1 more source

Diagnosing Systemic Mastocytosis: State of the Art

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 3, Page 551-560, June 2026.
ABSTRACT With the advent of effective multikinase and selective tyrosine kinase inhibitors in systemic mastocytosis, diagnosing this rare disease has been critical to improving patient morbidity and mortality. This state‐of‐the‐art review interprets the international diagnostic criteria, including differences between the WHO 5th edition classification ...
Anton Rets, Tracy I. George
wiley   +1 more source

Unexplained Elevated Vitamin B12: Consider Macro‐B12

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 3, Page 646-651, June 2026.
ABSTRACT Introduction Elevated vitamin B12 concentration can be caused by supplementation, liver disease, kidney disease, or myeloid malignancies. Persistent, unexplained elevations of vitamin B12 can raise concern among patients and may lead to invasive diagnostic procedures, including bone marrow biopsy.
Evelien G. E. Hurkmans   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy